The formation of extracellular matrix during chondrogenic differentiation of mesenchymal stem cells correlates with increased levels of xylosyltransferase I

Stem Cells

Volumn 24, Issue 10, 2006, Pages 2252-2261

  Prante, Christian ^a   Bieback, Karen ^b   Funke, Carsten ^a   Schön, Sylvia ^a   Kern, Susanne ^b   Kuhn, Joachim ^a   Gastens, Martin ^a   Kleesiek, Knut ^a   Götting, Christian ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b University of Ulm   (Germany)

Author keywords

Chondrogenesis; Differentiation; Matrix deposition; Mesenchymal stem cells; Proteoglycans; Xylosyltransferase I

Indexed keywords

AGGRECAN; ALPHA 4 N ACETYLHEXOSAMINYLTRANSFERASE; CHONDROITIN SULFATE; CORE PROTEIN; DECORIN; DERMATAN SULFATE; EPIMERASE; GLUCURONYL C5 EPIMERASE; GLYPICAN; HEPARAN SULFATE; MESSENGER RNA; SYNDECAN 2; TRANSFERASE; UNCLASSIFIED DRUG; XYLOSYLTRANFERASE 1; XYLOSYLTRANFERASE 11;

ADULT; AGED; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CHONDROGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; GENE CONTROL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INDUCTION; PROTEOGLYCAN SYNTHESIS; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION;

EID: 33749537685     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0508     Document Type: Article

References (36)

1. Majumdar MK, Thiede MA, Mosca JD et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998;176:57-66.
2. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
3. Yoo JU, Barthel TS, Nishimura K et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 1998;80:1745-1757.
4. Mackay AM, Beck SC, Murphy JM et al. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 1998;4:415-428.
5. Barry F, Boynton RE, Liu B et al. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: Differentiation-dependent gene expression of matrix components. Exp Cell Res 2001;268:189-200.
6. Schwartz NB. Regulation of chondroitin sulfate synthesis. Effect of beta-xylosides on synthesis of chondroitin sulfate proteoglycan, chondroitin sulfate chains, and core protein. J Biol Chem 1977;252:6316-6321.
7. Kearns AE, Campbell SC, Westley J et al. Initiation of chondroitin sulfate biosynthesis: A kinetic analysis of UDP-D-xylose: core protein beta-D-xylosyltransferase. Biochemistry 1991;30:7477-7483.
8. Schön S, Prante C, Bahr C et al. Cloning and recombinant expression of active full-length xylosytransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II. J Biol Chem 2006;281:14224-14231.
9. Götting C, Sollberg S, Kuhn J et al. Serum xylosyltransferase: A new biochemical marker of the sclerotic process in systemic sclerosis. J Invest Dermatol 1999;112:919-924.
10. Kuhn J, Mölle K, Brinkmann T et al. High-density tissue-like cultivation of JAR choriocarcinoma cells for the in vitro production of human xylosyltransferase. J Biotechnol 2003;103:191-196.
11. Kuhn J, Götting C, Schnölzer M et al. First isolation of human UDP-D-xylose: Proteoglycan core protein beta-D-xylosyltransferase secreted from cultured JAR choriocarcinoma cells. J Biol Chem 2001;276:4940-4947.
12. Götting C, Kuhn J, Zahn R et al. Molecular cloning and expression of human UDP-d-Xylose:proteoglycan core protein beta-d-xylosyltransferase and its first isoform XT-II. J Mol Biol 2000;304:517-528.
13. Hagner-McWhirter A, Li JP, Oscarson S et al. Irreversible glucuronyl C5-epimerization in the biosynthesis of heparan sulfate. J Biol Chem 2004;279:14631-14638.
14. Bieback K, Kern S, Klüter H et al. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. STEM CELLS 2004;22:625-634.
15. Kuhn J, Müller S, Schnölzer M et al. High-level expression and purification of human xylosyltransferase I in High Five insect cells as biochemically active form. Biochem Biophys Res Commun 2003;312:537-544.
16. Schönherr E, Hausser H, Beavan L et al. Decorin-type I collagen interaction. Presence of separate core protein-binding domains. J Biol Chem 1995;270:8877-8883.
17. Götting C, Müller S, Schöttler M et al. Analysis of the DXD motifs in human xylosyltransferase I required for enzyme activity. J Biol Chem 2004;279:42566-42573.
18. Fortier LA, Nixon AJ, Williams J et al. Isolation and chondrocytic differentiation of equine bone marrow-derived mesenchymal stem cells. Am J Vet Res 1998;59:1182-1187.
19. Nakata K, Nakahara H, Kimura T et al. Collagen gene expression during chondrogenesis from chick periosteum-derived cells. FEBS Lett 1992;299:278-282.
20. Pogany G, Hernandez DJ, Vogel KG. The in vitro interaction of proteoglycans with type I collagen is modulated by phosphate. Arch Biochem Biophys 1994;313:102-111.
21. Reed CC, Iozzo RV. The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J 2002;19:249-255.
22. Milan AM, Sugars RV, Embery G et al. Modulation of collagen fibrillogenesis by dentinal proteoglycans. Calcif Tissue Int 2005;76:127-135.
23. Tiedemann K, Larsson T, Heinegard D et al. The glucuronyl C5-epimerase activity is the limiting factor in the dermatan sulfate biosynthesis. Arch Biochem Biophys 2001;391:65-71.
24. Scott JE, Orford CR, Hughes EW. Proteoglycan-collagen arrangements in developing rat tail tendon. An electron microscopical and biochemical investigation. Biochem J 1981;195:573-581.
25. Pringle GA, Dodd CM. Immunoelectron microscopic localization of the core protein of decorin near the d and e bands of tendon collagen fibrils by use of monoclonal antibodies. J Histochem Cytochem 1990;38:1405-1411.
26. Fleischmajer R, Fisher LW, MacDonald ED et al. Decorin interacts with fibrillar collagen of embryonic and adult human skin. J Struct Biol 1991;106:82-90.
27. Keene DR, San Antonio JD, Mayne R et al. Decorin binds near the C terminus of type I collagen. J Biol Chem 2000;275:21801-21804.
28. Molteni A, Modrowski D, Hott M et al. Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro. Bone 1999;24:337-347.
29. Kirn-Safran CB, Gomes RR, Brown AJ et al. Heparan sulfate proteoglycans: Coordinators of multiple signaling pathways during chondrogenesis. Birth Defects Res C Embryo Today 2004;72:69-88.
30. Gomes RR Jr., Farach-Carson MC, Carson DD. Perlecan functions in chondrogenesis: Insights from in vitro and in vivo models. Cells Tissues Organs 2004;176:79-86.
31. Gomes R, Kirn-Safran C, Farach-Carson MC et al. Perlecan: An important component of the cartilage pericellular matrix. J Musculoskelet Neuronal Interact 2002;2:511-516.
32. French MM, Gomes RR Jr., Timpl R et al. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. J Bone Miner Res 2002;17:48-55.
33. Chen CW, Tsai YH, Deng WP et al. Type I and II collagen regulation of chondrogenic differentiation by mesenchymal progenitor cells. J Orthop Res 2005;23:446-453.
34. French MM, Smith SE, Akanbi K et al. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J Cell Biol 1999;145:1103-1115.
35. Rodén L. Structure and metabolism of connective tissue proteoglycans. In: Lennarz WJ, ed. The Biochemistry of Glycoproteins and Proteoglycans. New York: Plenum Publishing Corp., 1980:269-314.
36. Schön S, Huep G, Prante C et al. Mutational and functional analyses of xylosyltransferases and their implication in osteoarthritis. Osteoarthritis Cartilage 2006;14:442-448.